Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-24±³À°ÀÏÀÚ : 2019-11-24
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ ±×·£µåȦ
±³À°ÁÖÁ¦ :
Á¦47ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ
´ã´çÀÚ : ÇãÁö¼±
¿¬¶ôó : 02-3147-0930
À̸ÞÀÏ :
kse0930@ksecho.org ±³À°Á¾·ù : ³»°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 1200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í [»çÀü-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 8¸¸¿ø / Àü°øÀǹױ⟠4¸¸¿ø] [ÇöÀå-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 10¸¸¿ø / Àü°øÀǹױ⟠6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:00~08:10 Case 1 Presentation ±è´ëÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:10~08:25 KSTCVS: Why Do We Have to Undergo SAVR À̽ÂÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:25~08:40 KSIC: TAVR Is Best Option for This Patient ¹Ú´ö¿ì(¿ï»êÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 08:40~08:45 Panel Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:45~08:55 Case 2 Presentation ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 08:55~09:10 KSTCVS: Why Do We Have to Undergo SAVR À̽ÂÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 09:10~09:25 KSIC: TAVR Is Best Option for This Patient ¹Ú´ö¿ì(¿ï»êÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 09:25~09:30 Panel Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 10:30~10:45 Long-term Survival of Asymptomatic Patients with Very Severe Aortic Stenosis Early Surgery versus Conventional Treatment À̽¾Æ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 10:45~11:00 Diffuse myocardial fibrosis and diastolic dysfunction in aortic stenosis ÀÌÇöÁ¤(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:00~11:15 Prognostic Value of Left Ventricular Global Longitudinal Strain during Dobutamine Stress Echocardiography in Patients with Low-flow Low-gradient Severe Aortic Stenosis ±è´Ù·¡(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:15~11:30 Characteristics of Left Atrial Mechanical Function in Subjects with Mitral Annular Calcification A study with 2D and 3D speckle tracking echocardiography ÃÖÀÚ¿¬(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 11:30~11:45 Fate of Non-dysfunctional Bicuspid Aortic Valve With or Without Aortopathy Insight a Large Korean Registry ¼Û½ÅÁ¤(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 11:45~11:50 Panel Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 13:05~13:30 Recent update on Oral Anticoagulant Therapy Á¶Àͼº(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 13:30~13:55 Should we deal with adherence in hypertensive patients? ÀÓÁ¾·¡(Á¾±Ù´ç È¿Á¾¿¬±¸¼Ò)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 13:55~14:00 Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:00~14:20 Echo Provides More Than We Think ±è¿ëÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:20~14:40 Assessing Left Ventricular Diastolic Function in the Catheterization Laboratory ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 14:40~15:00 Growing Evidence of CMR for Hemodynamic Measurement ±è³²±¹(¿ï»êÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 15:00~15:20 Panel Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:00~16:15 Update of PH and Evidence-based Treatment Algorithm ÀåÁ¤À±(°æ»óÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:15~16:30 How to Diagnose and Manage PH Due to Left Heart Disease ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:30~16:45 How to Diagnose and Manage CTEPH À强¾Æ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 1 16:45~17:00 RV & Its Load in Pulmonary Hypertension ±è¼ºÈ¯(°í·ÁÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 1 17:00~17:20 Panel Discussion ()
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:00~08:15 The Use of Contrast Agents for MCE in Cardiomyopathy Han Wei(The First Affiliated Hosp. of Harbin Medical Univ)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:15~08:30 Advanced Imaging Techniques in Left Atrial Structure and Function ½Å¼ºÈñ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:30~08:45 Echocardiography for Complication of Mitral Valve Repair Fei Hongwen(Guangdong Provincial Cardiovascular Institute)
±³À°½Ã°£ 11-24 ºñ½ºÅ¸È¦ 2 08:45~09:00 Machine learning in echocardiography, supervised or unsupervised? À̽ÂÇ¥(¼¿ïÀÇ´ë)
Åä·Ð 11-24 ºñ½ºÅ¸È¦ 2 09:00~09:20 Panel Discussion ()